NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球罕見病基因檢測市場規模調查:按類型、技術、專業、最終用途、地區預測(2021-2027)

Global Rare Disease Genetic Testing Market Size study, by Type Technology Specialty End-use and Regional Forecasts 2021-2027

出版商 Bizwit Research & Consulting LLP 商品編碼 1006407
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
全球罕見病基因檢測市場規模調查:按類型、技術、專業、最終用途、地區預測(2021-2027) Global Rare Disease Genetic Testing Market Size study, by Type Technology Specialty End-use and Regional Forecasts 2021-2027
出版日期: 2021年05月11日內容資訊: 英文
簡介

2020 年全球罕見病基因檢測市場規模達到約 9.186 億美元。

在 2021-2027 年的預測期內,市場預計將以超過 10.9% 的健康增長率增長。

罕見病基因檢測是一項檢測,顯示目前已知會導致人類疾病的所有基因的範圍。據報導,大約有 6,000 個基因與臨床相關。這些基因包含懷疑與特定疾病相關的基因或基因區域。這增加了已經存在的基因數量,因此,收集了足夠的數據以繼續臨床研究以進行未來發現,進一步擴大該領域的市場增長機會。..

這些疾病對人類構成威脅,需要及時準確地進行診斷。這顯然是市場的推動力。對這些情況缺乏認識是市場面臨的主要挑戰。疾病的誤診和乾預可能後來證明不適用於潛在的疾病。因此,迫切需要提高對疾病這些方面的認識,包括臨床診斷和可用診斷方法的挑戰。除了上述所有因素外,數據收集和臨床實踐解釋方面的技術進步也在推動市場發展。市場參與者已做出各種努力來收集來自不同種族的數據。

本報告調查了全球罕見病基因檢測市場,按類型、技術、專業、最終用途、地區和進入市場的公司概況提供了市場概況、趨勢。

目錄

第 1 章執行摘要

第二章全球罕見病基因檢測市場的定義和範圍

第三章全球罕見病基因檢測市場機制

  • 罕見病基因檢測市場影響分析(2019-2027)

第四章世界罕見病基因檢測市場行業分析

  • 波特的 5 力模型
  • PEST 分析
  • 投資採用模式
  • 分析師建議和結論

第 5 章全球罕見病基因檢測市場,按疾病類型

  • 市場快照
  • 全球罕見病基因檢測市場,按疾病類型:性能-潛力分析
  • 全球罕見病基因檢測市場的估計和預測,按疾病類型:2018-2027(10億美元)
  • 罕見病基因檢測市場,細分市場分析
    • 神經系統疾病
    • 免疫疾病
    • 血液系統疾病
    • 內分泌和代謝紊亂
    • 癌症
    • 肌肉骨骼疾病
    • 心血管疾病
    • 皮膚病
    • 其他罕見病

按技術分列的第 6 章全球罕見病基因檢測市場

  • 市場快照
  • 全球罕見病基因檢測市場,按技術:性能-潛力分析
  • 全球罕見病基因檢測市場預估和預測,按技術:2018-2027(10億美元)
  • 罕見病基因檢測市場,細分市場分析
    • 新一代測序
    • 陣列技術
    • 基於 PCR 的測試
    • 桑格法
    • 核型分析

第 7 章全球罕見病基因檢測市場,按專業

  • 市場快照
  • 全球罕見病基因檢測市場,按專業:性能-潛力分析
  • 全球罕見病基因檢測市場的估計和預測,按專業:2018-2027(10億美元)
  • 罕見病基因檢測市場,細分市場分析
    • 分子遺傳學檢測
    • 染色體基因檢測
    • 生化基因檢測

第 8 章按最終用途劃分的全球罕見病基因檢測市場

  • 市場快照
  • 按最終用途劃分的全球罕見病基因檢測市場:性能-潛力分析
  • 全球罕見病基因檢測市場的估計和預測,按最終用途:2018-2027(10億美元)
  • 罕見病基因檢測市場,細分市場分析
    • 研究院,CRO
    • 醫院和診所
    • 診斷實驗室

第 9 章全球罕見病基因檢測市場,區域分析

  • 區域市場快照
  • 北美
    • 美國罕見病綜合檢測市場
    • 加拿大罕見病基因檢測市場
  • 歐洲快照
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他
  • 亞太地區概覽
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他
  • 拉丁美洲快照
    • 巴西
    • 墨西哥
  • 其他

第10章衝突信息

  • 頂級市場策略
  • 公司簡介
    • Quest Diagnostics Inc
    • Centogene N.V.
    • Invitae Corporation
    • 3billion, Inc.
    • Arup Laboratories
    • Eurofins Scientific
    • Strand Life Sciences
    • Ambry Genetics
    • Perkin Elmer, Inc.
    • Macrogen, Inc.

第11章 調查流程

目錄

Global Rare Disease Genetic Testing Market is valued approximately USD 0.9186 Billion in 2020 and is anticipated to grow with a healthy growth rate of more than 10.9% over the forecast period 2021-2027. Rare Disease Genetic Testing is a test which presents the range of all the genes which are currently known to cause human disease. There are about 6000 genes which reported to be clinically relevant. These genes contains a select set of genes or gene region which are suspected to have relationship with certain diseases. This lead to a rise in the number of already present genes and as a result it further increased the market growth opportunity for this sector as it allows to collect sufficient amount of data which enables to continue clinical research for future discoveries. These diseases possess a threat to the mankind and needs to be diagnosed timely and accurately. This proves to be a driving factor for the market. The lack of awareness to these conditions is a primary challenge for the market. The Misdiagnosis of the diseases can result in interventions which could later be considered inappropriate for the underlying disorder. Therefore there is an urgent need to raise awareness about the aspects of these diseases like the challenges concerning with regard to diagnosis and clinical implementation of available diagnostic ways. Along with all the above stated factors technological advancements in collection of data and interpretation for clinical practice has also driven the market. Various efforts have been made by the market players in order to collect data from different ethnicities.

The regional analysis of global Rare Disease Genetic Testing Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leader in Genetic Testing Market with an overall share of 47% of the total market in 2019.There will be a surge in the number of patients in the coming years this will further allow the market to grow. On the other hand, Asia Pacific is expected to grow more significantly in the coming years due to the increased awareness and rising populations in the Asian countries.

Major market player included in this report are:

Quest Diagnostics Inc.

Centogene N.V.

Invitae Corporation

3billion, Inc.

Arup Laboratories

Eurofins Scientific

Strand Life Sciences

Ambry Genetics

Perkin Elmer, Inc.

Macrogen, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:Neurological Disorders

Immunological Disorders

Hematology Diseases

Endocrine & Metabolism Diseases

Cancer

Musculoskeletal Disorders

Cardiovascular Disorders

Dermatology Diseases

Other Rare Diseases

By Technology:Next Generation Sequencing

Array Technology

PCR - based Testing

FISH

Sanger Sequencing

Karyotyping

By Specialty:Molecular Genetic Tests

Chromosomal Genetic Tests

Biochemical Genetic Tests

By End-use:Research Laboratories & CROs

Hospitals & Clinics

Diagnostic Laboratories

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019

Base year - 2020

Forecast period - 2021 to 2027

Target Audience of the Global Rare Disease Genetic Testing Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1.Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. Rare Disease Generic Testing Market , by Region, 2019-2027 (USD Billion)
    • 1.2.2. Rare Disease Generic Testing Market , by Disease Type, 2019-2027 (USD Billion)
    • 1.2.3. Rare Disease Generic Testing Market , by Technology Outlook, 2019-2027 (USD Billion)
    • 1.2.4. Rare Disease Generic Testing Market , by Speciality Outlook, 2019-2027 (USD Billion)
    • 1.2.5. Rare Disease Generic Testing Market , by End use Outlook, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Rare Disease Generic Testing Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Rare Disease Generic Testing Market Dynamics

  • 3.1. Rare Disease Generic Testing Market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
      • 3.1.1.1. The need for an accurate and timely diagnosis for rare conditions
    • 3.1.2. Market Challenges
      • 3.1.2.1. Lack of awareness about the diseases and its underlying effects
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Technological advancements in data collection and interpretation for clinical practice

Chapter 4. Global Rare Disease Generic Testing Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Rare Disease Generic Testing Market , by Disease Type

  • 5.1. Market Snapshot
  • 5.2. Global Rare Disease Generic Testing Market by Disease Type, Performance - Potential Analysis
  • 5.3. Global Rare Disease Generic Testing Market Estimates & Forecasts by Disease Type 2018-2027 (USD Billion)
  • 5.4. Rare Disease Generic Testing Market , Sub Segment Analysis
    • 5.4.1. Neurological Disorders,
    • 5.4.2. Immunological Disorders,
    • 5.4.3. Hematology Diseases,
    • 5.4.4. Endocrine & Metabolism Diseases,
    • 5.4.5. Cancer,
    • 5.4.6. Musculoskeletal Disorders,
    • 5.4.7. Cardiovascular Disorders,
    • 5.4.8. Dermatology Diseases,
    • 5.4.9. Other Rare Diseases

Chapter 6. Global Rare Disease Generic Testing Market , by Technology Outlook

  • 6.1. Market Snapshot
  • 6.2. Global Rare Disease Generic Testing Market by Technology Outlook, Performance - Potential Analysis
  • 6.3. Global Rare Disease Generic Testing Market Estimates & Forecasts by Technology Outlook 2018-2027 (USD Billion)
  • 6.4. Rare Disease Generic Testing Market , Sub Segment Analysis
    • 6.4.1. Next Generation Sequencing
    • 6.4.2. Array Technology
    • 6.4.3. PCR - based Testing
    • 6.4.4. FISH
    • 6.4.5. Sanger Sequencing
    • 6.4.6. Karyotyping

Chapter 7. Global Rare Disease Generic Testing Market , by Speciality Outlook

  • 7.1. Market Snapshot
  • 7.2. Global Rare Disease Generic Testing Market by Speciality Outlook, Performance - Potential Analysis
  • 7.3. Global Rare Disease Generic Testing Market Estimates & Forecasts by Speciality Outlook 2018-2027 (USD Billion)
  • 7.4. Rare Disease Generic Testing Market , Sub Segment Analysis
    • 7.4.1. Molecular Genetic Tests
    • 7.4.2. Chromosomal Genetic Tests
    • 7.4.3. Biochemical Genetic Tests

Chapter 8. Global Rare Disease Generic Testing Market , by End use Outlook

  • 8.1. Market Snapshot
  • 8.2. Global Rare Disease Generic Testing Market by End use Outlook, Performance - Potential Analysis
  • 8.3. Global Rare Disease Generic Testing Market Estimates & Forecasts by End use Outlook 2018-2027 (USD Billion)
  • 8.4. Rare Disease Generic Testing Market , Sub Segment Analysis
    • 8.4.1. Research Laboratories & CROs,
    • 8.4.2. Hospitals & Clinics,
    • 8.4.3. Diagnostic Laboratories

Chapter 9. Global Rare Disease Generic Testing Market , Regional Analysis

  • 9.1. Rare Disease Generic Testing Market , Regional Market Snapshot
  • 9.2. North America Rare Disease Generic Testing Market
    • 9.2.1. U.S. Rare Disease Generic Testing Market
      • 9.2.1.1. Disease Type breakdown estimates & forecasts, 2018-2027
      • 9.2.1.2. Technology Outlook breakdown estimates & forecasts, 2018-2027
      • 9.2.1.3. Speciality Outlook breakdown estimates & forecasts, 2018-2027
      • 9.2.1.4. End Use Outlook breakdown estimates & forecasts, 2018-2027
    • 9.2.2. Canada Rare Disease Generic Testing Market
  • 9.3. Europe Rare Disease Generic Testing Market Snapshot
    • 9.3.1. U.K. Rare Disease Generic Testing Market
    • 9.3.2. Germany Rare Disease Generic Testing Market
    • 9.3.3. France Rare Disease Generic Testing Market
    • 9.3.4. Spain Rare Disease Generic Testing Market
    • 9.3.5. Italy Rare Disease Generic Testing Market
    • 9.3.6. Rest of Europe Rare Disease Generic Testing Market
  • 9.4. Asia-Pacific Rare Disease Generic Testing Market Snapshot
    • 9.4.1. China Rare Disease Generic Testing Market
    • 9.4.2. India Rare Disease Generic Testing Market
    • 9.4.3. Japan Rare Disease Generic Testing Market
    • 9.4.4. Australia Rare Disease Generic Testing Market
    • 9.4.5. South Korea Rare Disease Generic Testing Market
    • 9.4.6. Rest of Asia Pacific Rare Disease Generic Testing Market
  • 9.5. Latin America Rare Disease Generic Testing Market Snapshot
    • 9.5.1. Brazil Rare Disease Generic Testing Market
    • 9.5.2. Mexico Rare Disease Generic Testing Market
  • 9.6. Rest of The World Rare Disease Generic Testing Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Quest Diagnostics Inc
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Centogene N.V.
    • 10.2.3. Invitae Corporation
    • 10.2.4. 3billion, Inc.
    • 10.2.5. Arup Laboratories
    • 10.2.6. Eurofins Scientific
    • 10.2.7. Strand Life Sciences
    • 10.2.8. Ambry Genetics
    • 10.2.9. Perkin Elmer, Inc.
    • 10.2.10. Macrogen, Inc.

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Rare Disease Generic Testing Market , report scope
  • TABLE 2. Global Rare Disease Generic Testing Market estimates & forecasts by Region 2018-2027 (USD Billion)
  • TABLE 3. Global Rare Disease Generic Testing Market estimates & forecasts by Disease Type 2018-2027 (USD Billion)
  • TABLE 4. Global Rare Disease Generic Testing Market estimates & forecasts by Technology Outlook 2018-2027 (USD Billion)
  • TABLE 5. Global Rare Disease Generic Testing Market estimates & forecasts by Speciality Outlook 2018-2027 (USD Billion)
  • TABLE 6. Global Rare Disease Generic Testing Market estimates & forecasts by End Use Outlook 2018-2027 (USD Billion)
  • TABLE 7. Global Rare Disease Generic Testing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 8. Global Rare Disease Generic Testing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 9. Global Rare Disease Generic Testing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 10. Global Rare Disease Generic Testing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 11. Global Rare Disease Generic Testing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 12. Global Rare Disease Generic Testing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 13. Global Rare Disease Generic Testing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 14. Global Rare Disease Generic Testing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 15. Global Rare Disease Generic Testing Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 16. Global Rare Disease Generic Testing Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 17. U.S. Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 18. U.S. Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 19. U.S. Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 20. Canada Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 21. Canada Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 22. Canada Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 23. UK Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 24. UK Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 25. UK Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 26. Germany Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 27. Germany Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 28. Germany Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 29. RoE Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 30. RoE Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 31. RoE Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 32. China Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 33. China Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 34. China Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 35. India Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 36. India Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 37. India Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 38. Japan Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 39. Japan Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 40. Japan Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 41. RoAPAC Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 42. RoAPAC Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 43. RoAPAC Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 44. Brazil Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 45. Brazil Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 46. Brazil Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 47. Mexico Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 48. Mexico Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 49. Mexico Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 50. RoLA Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 51. RoLA Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 52. RoLA Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 53. Row Rare Disease Generic Testing Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 54. Row Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 55. Row Rare Disease Generic Testing Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 56. List of secondary sources, used in the study of global Rare Disease Generic Testing Market
  • TABLE 57. List of primary sources, used in the study of global Rare Disease Generic Testing Market
  • TABLE 58. Years considered for the study
  • TABLE 59. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Rare Disease Generic Testing Market , research methodology
  • FIG 2. Global Rare Disease Generic Testing Market , market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Rare Disease Generic Testing Market , key trends 2020
  • FIG 5. Global Rare Disease Generic Testing Market , growth prospects 2021-2027
  • FIG 6. Global Rare Disease Generic Testing Market , porters 5 force model
  • FIG 7. Global Rare Disease Generic Testing Market , pest analysis
  • FIG 8. Global Rare Disease Generic Testing Market , value chain analysis
  • FIG 9. Global Rare Disease Generic Testing Market by segment, 2018 & 2027 (USD Billion)
  • FIG 10. Global Rare Disease Generic Testing Market by segment, 2018 & 2027 (USD Billion)
  • FIG 11. Global Rare Disease Generic Testing Market by segment, 2018 & 2027 (USD Billion)
  • FIG 12. Global Rare Disease Generic Testing Market by segment, 2018 & 2027 (USD Billion)
  • FIG 13. Global Rare Disease Generic Testing Market by segment, 2018 & 2027 (USD Billion)
  • FIG 14. Global Rare Disease Generic Testing Market , regional snapshot 2018 & 2027
  • FIG 15. North America Rare Disease Generic Testing Market 2018 & 2027 (USD Billion)
  • FIG 16. Europe Rare Disease Generic Testing Market 2018 & 2027 (USD Billion)
  • FIG 17. Asia pacific Rare Disease Generic Testing Market 2018 & 2027 (USD Billion)
  • FIG 18. Latin America Rare Disease Generic Testing Market 2018 & 2027 (USD Billion)
  • FIG 19. Global Rare Disease Generic Testing Market , company market share analysis (2020)